MENSNasdaqPharmaceutical Preparations
Jyong Biotech Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026
$1.93+0.09 (+4.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$57.07 (−96.73%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$4.67M
- EPS, diluted
- -$0.06
Four years at a glance
Fiscal years 2022 to 2025, USD
Operating income
-$2.61M
Net income
-$4.67M
EPS, diluted
-$0.06
Reported period